Curettage plus one or two cycles of cryosurgery for basal cell carcinoma with clinically nodular features: A prospective randomized controlled trial - 28/06/23
Doi : 10.1016/j.jaad.2023.04.070
Eva Backman, MD a, b, ⁎ 
, Sam Polesie, MD, PhD a, b, Martin Gillstedt, MSc a, b, Alexandra Sjöholm, RN a, b, Azad Nerwey, MD a, John Paoli, MD, PhD a, b
, Sam Polesie, MD, PhD a, b, Martin Gillstedt, MSc a, b, Alexandra Sjöholm, RN a, b, Azad Nerwey, MD a, John Paoli, MD, PhD a, b a Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
b Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden
∗Correspondence to: Eva Backman, MD, Department of Dermatology and Venereology, Sahlgrenska University Hospital, Gröna stråket 16, SE-413 45, Gothenburg, SwedenDepartment of Dermatology and Venereology, Sahlgrenska University HospitalGröna stråket 16GothenburgSE-413 45Sweden
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Wednesday 28 June 2023
Key words : basal cell carcinoma, cryosurgery, curettage, randomized clinical trial, skin cancer, skin neoplasms
| Funding sources: The study was financed by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-728261). |
|
| IRB approval status: The investigation was approved by the regional ethical review board in Gothenburg (Approval number 743-17). |
|
| Patient consent: Informed consent to study participation and scientific publication was obtained from all patients prior to inclusion. |
© 2023
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?